Day: November 24, 2021

Non-fungible tokens (NFTs) from over 20 renowned Japanese Manga Artists will be available.

SINGAPORE, Nov. 24, 2021 (GLOBE NEWSWIRE) — Digital Entertainment Asset Pte. Ltd (DEA), the Singapore-based blockchain and multimedia digital entertainment group providing the PlayMining blockchain gaming platform, today announced that the company will open its NFT Marketplace, PlayMining NFT Premier, on the Binance Smart Chain (BSC), a blockchain network built for running smart contract-based applications in February 2022.

The NFT market is expanding rapidly, and according to a report from the major decentralised app (dapps) ranking site DappRadar, the transaction volume hit $10.7 billion last quarter.

On PlayMining NFT Premier, NFTs are curated as one-of-a-kind pieces of digital art. Included are illustrations from world-renowned manga artists such as Hagiwara Kazushi (BASTARD!!) and Mikimoto Haruhiko (The Super Dimension Fortress Macross). Additional details of PlayMining NFT Premier will be published on DEA’s Medium page at a future date.

The artist/illustrator lineup for Playmining NFT Premier includes:

• Hagiwara Kazushi “Bastard!!: Heavy Metal, Dark Fantasy”
• Mikimoto Haruhiko “TV anime – Super Dimension Fortress Macross (Character Design)” “Kabaneri of the Iron Fortress (Character Design)”
• Okano Takeshi “Hell Teacher Nube”
• Fujiwara Kamui “Dragon Quest Biography – Emblem of Roto”
• Tsukiyama Kaya “The Knight in the Area”
• Ando Keishu “Hentai Kamen”
• Ogawa Etsushi “Chuuka Ichiban – Chinese Cooking Master”
• Nishii Terumi “JUJUTSU KAISEN (Chief Animation Director)” “Animation – JoJo’s Bizarre Adventure: Diamond is Unbreakable (Character Design)”
• Ayamine Rando “GetBackers: Recovery Service”
• Hiramatsu Shinji “Black Angels”
• Tanaka Kenichi “Lycee Overture Ver.Fate/Grand Order 2.0 (Card illustration)”
• Morita Takashi “A STORY OF ARSENE LUPIN AVENTURiER” “MOBILE SUIT GUNDAM UNICORN THE TRUTH OF E.F.F.”
• Azuma Takeshi “Ultimate Otaku Teacher”
• ume “TOKYO TOY BOX” “TOKYO TOY BOXes”
• Chi You “BUNNY BUNNY BANG!”
• MonoKubo “TV anime – Magical Girl Ore (Ending Visuals)” “Megalophilia” (Art work)”
• Fujima Takuya “Magical Girl Lyrical Nanoha ViVid” “TV Anime – Warlords of Sigrdrifa (Character Draft)”
• Keishin “Seven Days War (Theatrical Anime)”
• Yamaji Hidenori “Marry Grave” “Soara and Monster’s House”
• Nanaroku “Zettaini Hatarakitakunai Dungeon Master ga Damin wo Musaboru Made(Comicalize)” “Panzermaedchen(Art Book)”
• Asami Aoko “Kimi to tsugai ni narenai riyu”
• fuumi “Management of Novice Alchemist (Illustration)”
• Miyuki Ruria “”Nanatsu no maken ga shihai suru (Illustration)”
• VOFAN “Nisio Isin’s Monogataric series (Cover Illustration)”
• Fuzichoco “Magical Mirai 2020 (Key Visual)”
• DCrossbone “VORTEX 01 – MALEVOLENT”
• Mottun* “Idol Incidents (Character Design)”
• Ito Keiichiro “Mad Max: Fury Road (Pamphlet illustrations)”

PlayMining NFT Premier prevents data tampering and ensures data security by saving data semi-permanently through placing NFT metadata in IPFS (InterPlanetary File System). In addition to implementing the EIP-721 NFT standard, DEA will implement the EIP-2981 NFT Royalty Standard, which provides a standardised way to retrieve royalty payment information for non-fungible tokens (NFTs) to enable universal support for royalty payments across all NFT marketplaces and ecosystem participants.

DEA will contribute to improving benefits for creators by delivering high-quality NFTs to users with specifications that are evaluated on the public chain.

As one of the first companies to focus on NFTs even before the NFT boom began in earnest, DEA plans to not only sell NFTs as a store of value but also to develop in-game content that utilizes NFTs. The company plans to reach out to more users with high-quality NFTs through its marketplace on BSC. DEA will continue to utilize various blockchain technologies to deliver the contents and services provided by DEA to users all over the world.

Contact Information

Digital Entertainment Asset Pte. Ltd

Chikako Yamawaki
yamawaki@dea.sg

Chikae Kimura
kimura@dea.sg

Related Images

Image 1: BSC x PlayMining

NFT marketplace, PlayMining NFT Premier on Binance Smart Chain

Image 2: PlayMining NFT Premier “Astronaut”

By Hagiwara Kazushi

Image 3: PlayMining NFT Premier “Chinese Master Chef”

By Ogawa Etsushi

This content was issued through the press release distribution service at Newswire.com.

Attachment

• BSC x PlayMining

November 24, 2021

• Philips showcases world’s first spectral detector angio-CT solution at RSNA 2021
• Solution combines breakthrough spectral detector CT imaging and real-time fluoroscopy in a flexible environment where all modalities are operated through Philips Image-Guided Therapy System – Azurion with FlexArm
• Philips’ Spectral detector CT imaging in the interventional suite brings valuable additional information in minimally-invasive procedures for areas such as oncology, stroke, and trauma care

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its vision for interventional medicine by bringing its breakthrough spectral CT imaging technology into a hybrid Angio CT suite. By combining the company’s unique Spectral CT 7500 system and its Image-Guided Therapy System – Azurion with FlexArm in a single interventional suite solution, Philips aims to give interventionalists immediate table-side access to these two key imaging modalities so they can perform procedures requiring both CT and angio guidance in one room. For the development of this integrated solution Philips is closely collaborating with leading clinical institutes such as Mayo Clinic (Rochester, MN, U.S.) and Baptist Health’s Miami Cardiac & Vascular Institute (Miami, FL, U.S.). It is being presented at the 2021 Radiological Society of North America Annual Meeting (Chicago, USA, November 28 – December 2).

The goal of combining the breakthrough, first of a kind Spectral CT 7500 with the Azurion platform is to provide a seamless workflow environment in which all the necessary imaging modalities – are available directly at the patient table, fully controllable from the table-side work spot. When not in use, each modality glides smoothly away from the patient table into a parking position, giving the interventional team unrestricted access to the patient. Each system can work stand-alone if required. For interventionalists, it enables seamless efficient workflows without the need to move the patient from one imaging suite to another. For patients, this means their physicians can leverage the strengths of both systems during a single procedure.

Requiring just one scan to capture all the spectral information required to differentiate and quantify different tissues, Philips’ always-on spectral CT technology enables improved detection, delineation, and quantification of lesions, leading to better-informed planning for minimally-invasive procedures and more precise interventions. In oncology, spectral CT has also demonstrated a higher sensitivity in detecting malignant findings and has improved readings of incidental findings [1] [2].

“There has been a tremendous evolution in the image-guided therapy environment,” said Dr. Barry T. Katzen, founder and chief medical executive of Baptist’s Health’s Miami Cardiac & Vascular Institute. “We are really excited about the merger and integration of these technologies in that it might allow us to look at the treatment of a number of diseases in very new and innovative ways, potentially offering new treatment opportunities and improving patient care. I am looking forward to investigating the possibilities of this promising innovation.”

“With this innovation, we are taking a uniquely patient-centric approach, aimed at bringing the latest interventional imaging modalities to the patient table rather than moving the patient to the individual modalities,” said Karim Boussebaa, General Manager of Image Guided Therapy Systems at Philips. “We are excited to be co-creating the future of image guided therapy with leading clinical partners by combining the best of our award-winning modalities into a single suite.”

Follow @PhilipsLiveFrom for updates throughout RSNA 2021, and join Philips at RSNA 2021 where the company will spotlight its latest advanced technology driving connected workflows and smart connected imaging systems.

[1] Analysis by Aarhus University Hospital Aarhus, Denmark. Results from case studies are not predictive of results in other cases. Results in other cases may vary.
[2] Analysis by University Hospital Cleveland, USA. Results from case studies are not predictive of results in other cases. Results in other cases may vary.

For further information, please contact:

Joost Maltha
Philips Global Press Office
Tel: +31 610 558 116
Email: joost.maltha@philips.com

Kathy O’Reilly
Philips Global Press Office
Tel.  + 1 978-221-8919
E-mail  kathy.oreilly@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 17.3 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachment

• Philips Angio CT

This order reinforces our strong booking momentum in the electrolyzer business and puts Plug Power well on its path to achieving its 2022 electrolyzer sales plan

LATHAM, N.Y., Nov. 24, 2021 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a leading provider of turnkey hydrogen solutions for the global green hydrogen market, today announces it has been selected by Fertiglobe (ADX: FERTIGLB) the strategic partnership between OCI NV (Euronext: OCI) and the Abu Dhabi National Oil Company (ADNOC) and Scatec ASA (OSE: SCATC), the Sovereign Fund of Egypt and Orascom Construction (NASDAQ Dubai: OC; EGX: ORAS), as the technology provider for a 100 megawatts electrolyzer to produce green hydrogen as feedstock for up to 90,000 tons of green ammonia production at EBIC in Ain Sokhna, Egypt.

Egypt is an ideal location to produce green hydrogen given its unique renewables profile with strong solar and wind loads, and close to markets with a hydrogen deficit. Green ammonia, produced from renewable energy such as solar and wind instead of natural gas, is a versatile product that is an ideal carrier fuel to store and transport hydrogen, and can help decarbonize numerous sectors which represent around 80% of current global Greenhouse Gas (GHG) emissions, including as an important alternative fuel in the power sector in Japan and other countries.

“Plug Power congratulates the members of Egypt’s Green Hydrogen Consortium, including Fertiglobe, Orascom Construction and others, on their plans to develop the country’s first green hydrogen production facility,” said Andy Marsh, CEO of Plug Power. “We are thrilled by the Consortium’s exciting move to put Egypt and the MENA region on the green hydrogen map.”

Marsh Continued, “This order reinforces our strong booking momentum in the electrolyzer business and puts Plug Power well on its path to achieving its 2022 electrolyzer sales plan. Plug Power is aggressively pursuing an extensive sales pipeline of green hydrogen and green ammonia projects. We continue to establish meaningful global partnerships in the green hydrogen economy where we can deliver our commercial electrolyzer solutions.”

Nassef Sawiris, Executive Chairman of OCI NV, commented: “We are excited to announce this key milestone in this essential piece of our hydrogen strategy. Plug Power is a leader in electrolysis technology, and this strategic partnership further solidifies our execution strategy. At start-up, this will be the largest green hydrogen and largest green ammonia application globally. Construction is expected to follow an accelerated schedule to showcase the green hydrogen facility during COP 27 in Egypt in November 2022, highlighting Egypt’s and Fertiglobe’s growing leadership in the renewable energy markets and commitment to a greener future.”

Ahmed El-Hoshy, Chief Executive Officer of Fertiglobe, commented: “This is a huge step forward in our ambition to decarbonize our footprint to net zero by 2050, and simultaneously help our customers decarbonize. As an early mover in clean hydrogen-based fuels, we are pleased that Fertiglobe is partnering with Plug Power to deploy cutting edge technology at scale.”

About Plug Power

Plug Power is building the hydrogen economy as the leading provider of comprehensive hydrogen fuel cell (HFC) turnkey solutions. The Company’s innovative technology powers electric motors with hydrogen fuel cells amid an ongoing paradigm shift in the power, energy, and transportation industries to address climate change and energy security, while providing efficiency gains and meeting sustainability goals. Plug Power created the first commercially viable market for hydrogen fuel cell (HFC) technology. As a result, the Company has deployed over 50,000 fuel cell systems for e-mobility, more than anyone else in the world, and has become the largest buyer of liquid hydrogen, having built and operated a hydrogen highway across North America. Plug Power delivers a significant value proposition to end-customers, including meaningful environmental benefits, efficiency gains, fast fueling, and lower operational costs. Plug Power’s vertically integrated GenKey solution ties together all critical elements to power, fuel, and provide service to customers such as Amazon, BMW, The Southern Company, Carrefour, and Walmart. The Company is now leveraging its know-how, modular product architecture and foundational customers to rapidly expand into other key markets including zero-emission on-road vehicles, robotics, and data centers.

About Fertiglobe

Fertiglobe is the world’s largest seaborne exporter of urea and ammonia combined, and an early mover in clean ammonia. Fertiglobe’s production capacity comprises of 6.7 million tons of urea and merchant ammonia, produced at four subsidiaries in the UAE, Egypt and Algeria, making it the largest producer of nitrogen fertilizers in the Middle East and North Africa (MENA), and benefits from direct access to six key ports and distribution hubs on the Mediterranean Sea, Red Sea, and the Arab Gulf. Headquartered in Abu Dhabi and incorporated in Abu Dhabi Global Market (ADGM), Fertiglobe employs more than 2,600 employees and was formed as a strategic partnership between OCI N.V. (“OCI”) and the Abu Dhabi National Oil Company (“ADNOC”). Fertiglobe is listed on the Abu Dhabi Securities Exchange (“ADX”) under the symbol “FERTIGLB” and ISIN “AEF000901015. To find out more, visit: www.fertiglobe.com

About OCI N.V.

OCI N.V. (Euronext: OCI) is a leading global producer and distributor of hydrogen-based products providing low carbon fertilizers, fuels, and feedstocks to agricultural, transportation, and industrial customers around the world. OCI’s production capacity spans four continents and comprises approximately 16.2 million metric tons per year of hydrogen-based products including nitrogen fertilizers, methanol, biofuels, diesel exhaust fluid, melamine, and other products. OCI has more than 3,600 employees, is headquartered in the Netherlands and listed on Euronext in Amsterdam. For more information, please visit www.oci.nl

Plug Power Safe Harbor Statement
This communication contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve significant risks and uncertainties about Plug Power Inc.(“PLUG”), including but not limited to statements about PLUG’s expectations regarding its multi-year investment and growth, PLUG’s clean hydrogen technology and fuel cell solutions playing a critical role in achieving climate and decarbonization goals, deepening of relationships with key stakeholders, and acceleration of demand and adoption of hydrogen technology. You are cautioned that such statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times that, or by which, such performance or results will have been achieved. Such statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in these statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of PLUG in general, see PLUG’s public filings with the Securities and Exchange Commission, including the “Risk Factors” section of PLUG’s Annual Report on Form 10-K for the year ended December 31, 2020. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made as of the date hereof, and PLUG undertakes no obligation to update such statements as a result of new information.

SOURCE: PLUG POWER

Plug Power Media Contact
Caitlin Coffee
Allison+Partners
(312) 635-8204
PlugPR@allisonpr.com

PHILOGEN ANNOUNCES NEW COLLABORATION WITH JANSSEN TO DISCOVER SMALL MOLECULE THERAPEUTICS

Siena, Italy, November 24, 2021 – Philogen S.p.A., a clinical-stage biotechnology company focused on antibody and small molecule-based targeted therapeutics, today announces that its wholly-owned Swiss subsidiary, Philochem AG, has entered into a new collaboration and option agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover new small molecules of pharmaceutical interest utilizing Philochem’s novel lead-generation technologies. The agreement was facilitated by Johnson & Johnson Innovation.

Under the terms of the agreement, Philochem will work with Janssen to apply its proprietary DNA-encoded chemical library technology platform, seeking to identify small molecule compounds that bind to specific targets. Janssen may exercise the options to use these identified ligands as candidates for further drug discovery and development activities.

Prof. Dario Neri, co-founder and Chief Executive Officer of Philogen commented: “We are pleased to establish another collaboration with Janssen and we hope our technology will contribute to providing innovative treatments for serious unmet medical needs.”

Philogen’s main focus is on the discovery and development of targeted anti-cancer therapeutics, which selectively accumulate at the site of disease helping spare normal tissue. Besides the successful development of antibody-cytokine fusions, Philogen has used its encoded library platform to identify small organic ligands with ultra-high affinity for tumor-associated antigens. These ligands are used for the selective delivery of diagnostic and therapeutic payloads including radionuclides or cytotoxic drugs to the site of disease. This approach is complementary to the use of antibody-cytokine fusions and the small molecule product candidates developed by Philogen have already obtained clinical proof-of-principle validation.

No financial details of the agreement were disclosed.

About Philogen

Philogen is a Swiss-Italian clinical-stage biotechnology company listed on the Italian Stock Exchange. It is engaged in the discovery and development of novel pharmaceutical and biopharmaceutical products. Philogen’s strategy is to deliver bioactive agents, for example cytokines or drugs, to the site of disease using antibodies and other ligands that specifically and efficiently target stromal antigens. This technology has generated a strong proprietary pipeline of clinical-stage products and preclinical compounds in an array of disease indications. Philogen is headquartered in Siena, Italy, and has research activities at its subsidiary company Philochem near Zurich, Switzerland. Philogen has signed agreements with several major pharmaceutical companies. For more information, please visit www.philogen.com and www.philochem.com .

Philogen contacts

Dr. Christian Lizak (Business Development), christian.lizak@philogen.com

Dr. Emanuele Puca (Investor Relations), emanuele.puca@philogen.com

+41 (0) 43 544 88 00

Consilium Strategic Communications contacts

Mary-Jane Elliott, Davide Salvi

Philogen@consilium-comms.com

TEMECULA, Calif., Nov. 24, 2021 (GLOBE NEWSWIRE) — Nikkiso’s Clean Energy & Industrial Gases Group (“Nikkiso”) announced the signing of a Memorandum of Understanding (MOU) with Tatsuno North America, Inc. (“Tatsuno”) to initiate cooperation as the Authorized Aftermarket Partner for their Hydrogen Dispensers in North America to establish a framework for cooperation.

Under the terms of the MOU, Nikkiso will provide spare parts, maintenance and repair services of Tatsuno’s Hydrogen Dispensers from Nikkiso’s network of North America facilities that are near the end user’s hydrogen refilling stations. In addition, Nikkiso will install and commission new dispensers, including the provision of engineering and pre-setup support for Tatsuno’s charging and fleet management systems.

Hydrogen dispensing is a new and developing market and an important component of the Hydrogen fueling station solution. These dispensers provide safe and fast fueling for both light duty and heavy-duty vehicles at 350 barg and 700 barg.

“The newly formed partnership with Nikkiso Cryogenic Industries and Tatsuno strengthens our Hydrogen presence and allows us to better serve the North American markets,” according to Teru Murakami, General Manager, Cryogenic Business Department, Nikkiso Co., Ltd. “We are looking forward to providing Tatsuno’s customers top quality service and support.”

Nikkiso Cryogenic Industries was chosen for this new, long-term partnership because of their relationships and hydrogen experience. They are also able to provide expanded services including complete Hydrogen fueling system solutions. This partnership will also provide new jobs for the local service facility economies.

ABOUT CRYOGENIC INDUSTRIES
Cryogenic Industries, Inc. (now a member of Nikkiso Co., Ltd.) member companies manufacture engineered cryogenic gas processing equipment and small-scale process plants for the liquefied natural gas (LNG), well services and industrial gas industries. Founded over 50 years ago, Cryogenic Industries is the parent company of ACD, Cosmodyne and Cryoquip and a commonly controlled group of approximately 20 operating entities.

For more information please visit www.nikkisoCEIG.com and www.nikkiso.com.

MEDIA CONTACT:
Anna Quigley +1.951.383.3314
aquigley@cryoind.com